Design of smart nanomaterials for drug and gene delivery

Journal of Biomaterials and Tissue Engineering

Volumn 1, Issue 1, 2011, Pages 6-29

  Vallet Regí, María ^a,b   Ruiz Hernández, Eduardo ^a,b   González, Blanca ^a,b   Baeza, Alejandro ^a,b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

Drug delivery nanodevices; Magnetic nanoparticles; Mesoporous silica nanoparticles; Nonviral vectors for gene transfection; Stimuli responsive nanomaterials

Indexed keywords

EID: 84856824481     PISSN: 21579083     EISSN: 21579091     Source Type: Journal    
DOI: 10.1166/jbt.2011.1006     Document Type: Review

References (237)

1. J. M. Rosenholm, C. Sahlgren, and M. Linden, Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles-Opportunities & challenges. Nanoscale 2, 1870 (2010).
2. C. Minelli, S. B. Lowe, and M. M. Stevens, Engineering nanocomposite materials for cancer therapy. Small 6, 2336 (2010).
3. D. H. Kim, N. S. Lu, R. Ghaffari, Y. S. Kim, S. P. Lee, L. Z. Xu, J. A. Wu, R. H. Kim, J. Z. Song, Z. J. Liu, J. Viventi, B. de Graff, B. Elolampi, M. Mansour, M. J. Slepian, S. Hwang, J. D. Moss, S. M. Won, Y. G. Huang, B. Litt, and J. A. Rogers, Materials for multifunctional balloon catheters with capabilities in cardiac electrophysiological mapping and ablation therapy. Nat. Mater. 10, 316 (2011).
4. C. Sanchez, K. J. Shea, and S. Kitagawa, Recent progress in hybrid materials science. Chem. Soc. Rev. 40, 471 (2011).
5. P. Horcajada, T. Chalati, C. Serre, B. Gillet, C. Sebrie, T. Baati, J. F. Eubank, D. Heurtaux, P. Clayette, C. Kreuz, J. S. Chang, Y. K. Hwang, V. Marsaud, P. N. Bories, L. Cynober, S. Gil, G. Ferey, P. Couvreur, and R. Gref, Porous metal-organicframework nanoscale carriers as a potential platform for drug delivery and imaging. Nat. Mater. 9, 172 (2010).
6. K. Riehemann, S. W. Schneider, T. A. Luger, B. Godin, M. Ferrari, and H. Fuchs, Nanomedicine-Challenge and perspectives. Angew. Chem. Int. Ed. 48, 872 (2009).
7. A. A. Bhirde, V. Patel, J. Gavard, G. F. Zhang, A. A. Sousa, A. Masedunskas, R. D. Leapman, R. Weigert, J. S. Gutkind, and J. F. Rusling, Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano 3, 307 (2009).
8. M. S. Muthu and S. Singh, Targeted nanomedicines: Effective treatment modalities for cancer, AIDS and brain disorders. Nanomedicine 4, 105 (2009).
9. J. Kim, Y. Piao, and T. Hyeon, Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem. Soc. Rev. 38, 372 (2009).
10. C. R. Sun, K. Du, C. Fang, N. Bhattarai, O. Veiseh, F. Kievit, Z. Stephen, D. H. Lee, R. G. Ellenbogen, B. Ratner, and M. Q. Zhang, PEG-Mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: Their physicochemical properties and function in vivo. ACS Nano 4, 2402 (2010).
11. G. M. Whitesides, Nanoscience, nanotechnology, and chemistry. Small 1, 172 (2005).
12. D. M. Eigler and E. K. Schweizer, Positioning single atoms with a scanning tunneling microscope. Nature 344, 524 (1990).
13. G. Binnig, C. F. Quate, and C. Gerber, Atomic force microscope. Phys. Rev. Lett. 56, 930 (1986).
14. Z. M. Markovic, L. M. Harhaji-Trajkovic, B. M. Todorovic-Markovic, D. P. Kepic, K. M. Arsikin, S. P. Jovanovic, A. C. Pantovic, M. D. Dramicanin, and V. S. Trajkovic, In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes. Biomaterials 32, 1121 (2011).
15. T. K. Sau and A. L. Rogach, Nonspherical noble metal nanoparticles: Colloid-chemical synthesis and morphology control. Adv. Mater. 22, 1781 (2010).
16. R. Hao, R. J. Xing, Z. C. Xu, Y. L. Hou, S. Gao, and S. H. Sun, Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles. Adv. Mater. 22, 2729 (2010).
17. Y. L. Gao, W. L. Stanford, and W. C. W. Chan, Quantum-dotencoded microbeads for multiplexed genetic detection of nonamplified DNA samples. Small 7, 137 (2011).
18. M. C. Roco, The long view of nanotechnology development: The National Nanotechnology Initiative at 10 years. J. Nanopart. Res. 13, 427 (2011).
19. M. C. Roco and W. S. Bainbridge, Societal implications of nanoscience and nanotechnology: Maximizing human benefit. J. Nanopart. Res. 7, 1 (2005).
20. Y. N. Xia, P. D. Yang, Y. G. Sun, Y. Y. Wu, B. Mayers, B. Gates, Y. D. Yin, F. Kim, and Y. Q. Yan, One-dimensional nanostructures: Synthesis, characterization, and applications. Adv. Mater. 15, 353 (2003).
21. M. M. J. Treacy, T. W. Ebbesen, and J. M. Gibson, Exceptionally high Young's modulus observed for individual carbon nanotubes. Nature 381, 678 (1996).
22. G. M. Whitesides, J. P. Mathias, and C. T. Seto, Molecular selfassembly and nanochemistry-A chemical strategy for the synthesis of nanostructures. Science 254, 1312 (1991).
23. K. J. M. Bishop, C. E. Wilmer, S. Soh, and B. A. Grzybowski, Nanoscale forces and their uses in self-assembly. Small 5, 1600 (2009).
24. F. Balas, M. Arruebo, J. Urrutia, and J. Santamaría, Reported nanosafety practices in research laboratories worldwide. Nat. Nanotechnol. 5, 93 (2010).
25. S. M. Hussain, L. K. Braydich-Stolle, A. M. Schrand, R. C. Murdock, K. O. Yu, D. M. Mattie, J. J. Schlager, and M. Terrones, Toxicity evaluation for safe use of nanomaterials: Recent achievements and technical challenges. Adv. Mater. 21, 1549 (2009).
26. G. Oberdorster, A. Elder, and A. Rinderknecht, Nanoparticles and the brain: Cause for concern? J. Nanosci. Nanotechnol. 9, 4996 (2009).
27. H. F. Krug and P. Wick, Nanotoxicology: An interdisciplinary challenge. Angew. Chem. Int. Ed. 50, 1260 (2011).
28. G. Oberdorster, Safety assessment for nanotechnology and nanomedicine: Concepts of nanotoxicology. J. Intern. Med. 267, 89 (2010).
29. A. A. Shvedova and V. E. Kagan, The role of nanotoxicology in realizing the 'helping without harm' paradigm of nanomedicine: Lessons from studies of pulmonary effects of single-walled carbon nanotubes. J. Intern. Med. 267, 106 (2010).
30. J. J. Shi, A. R. Votruba, O. C. Farokhzad, and R. Langer, Nanotechnology in drug delivery and tissue engineering: From discovery to applications. Nano Lett. 10, 3223 (2010).
31. B. Fadeel, B. Kasemo, M. Malmsten, and M. Stromme, Nanomedicine: Reshaping clinical practice. J. Intern. Med. 267, 2 (2010).
32. M. Ferrari, Cancer nanotechnology: Opportunities and challenges. Nat. Rev. Cancer 5, 161 (2005).
33. H. J. Yao, R. J. Ju, X. X. Wang, Y. Zhang, R. J. Li, Y. Yu, L. A. Zhang, and W. L. Lu, The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery. Biomaterials 32, 3285 (2011).
34. P. Huang, Z. Li, J. Lin, D. Yang, G. Gao, C. Xu, L. Bao, C. Zhang, K. Wang, H. Song, H. Hu, and D. Cui, Photosensitizer-conjugated magnetic nanoparticles for in vivo simultaneous magnetofluorescent imaging and targeting therapy. Biomaterials 32, 3447 (2011).
35. C. P. Tsai, C. Y. Chen, Y. Hung, F. H. Chang, and C. Y. Mou, Monoclonal antibody-functionalized mesoporous silica nanoparticles (MSN) for selective targeting breast cancer cells. J. Mater. Chem. 19, 5737 (2009).
36. A. A. Burns, J. Vider, H. Ow, E. Herz, O. Penate-Medina, M. Baumgart, S. M. Larson, U. Wiesner, and M. Bradbury, Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett. 9, 442 (2009).
37. P. Debbage, Targeted drugs and nanomedicine: Present and future. Curr. Pharm. Design 15, 153 (2009).
38. R. Duncan, Nanomedicine gets clinical. Mater. Today 8, 16 (2005).
39. M. Vallet-Regí, Nanostructured mesoporous silica matrices in nanomedicine. J. Intern. Med. 267, 22 (2010).
40. H. C. Tsai, W. H. Chang, C. L. Lo, C. H. Tsai, C. H. Chang, T. W. Ou, T. C. Yen, and G. H. Hsiue, Graft and diblock copolymer multifunctional micelles for cancer chemotherapy and imaging. Biomaterials 31, 2293 (2010).
41. C. C. P. Verstappen, J. J. Heimans, K. Hoekman, and T. J. Postma, Neurotoxic complications of chemotherapy in patients with cancer-Clinical signs and optimal management. Drugs 63, 1549 (2003).
42. J. H. Park, L. Gu, G. von Maltzahn, E. Ruoslahti, S. N. Bhatia, and M. J. Sailor, Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat. Mater. 8, 331 (2009).
43. H. J. Chung and T. G. Park, Self-assembled and nanostructured hydrogels for drug delivery and tissue engineering. Nano Today 4, 429 (2009).
44. J. H. Park, G. von Maltzahn, E. Ruoslahti, S. N. Bhatia, and M. J. Sailor, Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew. Chem. Int. Ed. 47, 7284 (2008).
45. M. S. L. Raddatz, A. Dolf, E. Endl, P. Knolle, M. Famulok, and G. Mayer, Enrichment of cell-targeting and population-specific aptamers by fluorescence-activated cell sorting. Angew. Chem. Int. Ed. 47, 5190 (2008).
46. J. M. Nam, C. S. Thaxton, and C. A. Mirkin, Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science 301, 1884 (2003).
47. S. I. Stoeva, J. S. Lee, C. S. Thaxton, and C. A. Mirkin, Multiplexed DNA detection with biobarcoded nanoparticle probes. Angew. Chem. Int. Ed. 45, 3303 (2006).
48. T. J. Webster and E. S. Ahn, Nanostructured biomaterials for tissue engineering bone, Tissue Engineering Ii: Basics of Tissue Engineering and Tissue Applications, Springer-Verlag Berlin, Berlin (2007), p. 275.
49. M. K. Wagner, F. Li, J. J. Li, X. F. Li, and X. C. Le, Use of quantum dots in the development of assays for cancer biomarkers. Anal. Bioanal. Chem. 397, 3213 (2010).
50. B. Y. S. Kim, J. T. Rutka, and W. C. W. Chan, Current concepts: Nanomedicine. New Engl. J. Med. 363, 2434 (2010).
51. D. L. Shi, Integrated multifunctional nanosystems for medical diagnosis and treatment. Adv. Func. Mater. 19, 3356 (2009).
52. Z. Y. Liao, H. J. Wang, X. D. Wang, P. Q. Zhao, S. Wang, W. Y. Su, and J. Chang, Multifunctional nanoparticles composed of a poly(DL-lactide-coglycolide) core and a paramagnetic liposome shell for simultaneous magnetic resonance imaging and targeted therapeutics. Adv. Func. Mater. 21, 1179 (2011).
53. M. Westphal, Z. Ram, V. Riddle, D. Hilt, and E. Bortey, G. Executive Comm Gliadel Study, Gliadel (R) wafer in initial surgery for malignant glioma: Long-term follow-up of a multicenter controlled trial. Acta Neurochir. 148, 269 (2006).
54. E. A. Lundström, R. K. Rencken, J. H. van Wyk, L. J. E. Coetzee, J. C. M. Bahlmann, S. Reif, E. A. Strasheim, M. C. Bigalke, A. R. Pontin, L. Goedhals, D. G. Steyn, C. F. Heyns, L. A. Aldera, T. M. Mackenzie, D. Purcea, P. Y. Grosgurin, and H. C. Porchet, Triptorelin 6-month formulation in the management of patients with locally advanced and metastatic prostate cancer an open-label, noncomparative, multicentre, phase III study. Clin. Drug Invest. 29, 757 (2009).
55. A. G. Roca, R. Costo, A. F. Rebolledo, S. Veintemillas-Verdaguer, P. Tartaj, T. Gonzalez-Carreño, M. P. Morales, and C. J. Serna, Progress in the preparation of magnetic nanoparticles for applications in biomedicine. J. Phys. D Appl. Phys. 42, 224002 (2009).
56. Q. A. Pankhurst, N. K. T. Thanh, S. K. Jones, and J. Dobson, Progress in applications of magnetic nanoparticles in biomedicine. J. Phys. D Appl. Phys. 42, 224001 (2009).
57. C. C. Berry, Progress in functionalization of magnetic nanoparticles for applications in biomedicine. J. Phys. D Appl. Phys. 42, 224003 (2009).
58. A. H. Lu, E. L. Salabas, and F. Schuth, Magnetic nanoparticles: Synthesis, protection, functionalization, and application. Angew. Chem. Int. Ed. 46, 1222 (2007).
59. C. Carbone, S. Gardonio, P. Moras, S. Lounis, M. Heide, G. Bihlmayer, N. Atodiresei, P. H. Dederichs, S. Blugel, S. Vlaic, A. Lehnert, S. Ouazi, S. Rusponi, H. Brune, J. Honolka, A. Enders, K. Kern, S. Stepanow, C. Krull, T. Balashov, A. Mugarza, and P. Gambardella, Self-assembled nanometer-scale magnetic networks on surfaces: Fundamental interactions and functional properties. Adv. Func. Mater. 21, 1212 (2011).
60. X. M. Lin and A. C. S. Samia, Synthesis, assembly and physical properties of magnetic nanoparticles. J. Magn. Magn. Mater. 305, 100 (2006).
61. D. A. Thompson and J. S. Best, The future of magnetic data storage technology. IBM J. Res. Dev. 44, 311 (2000).
62. R. Bardhan, W. X. Chen, M. Bartels, C. Pérez-Torres, M. F. Botero, R. W. McAninch, A. Contreras, R. Schiff, R. G. Pautler, N. J. Halas, and A. Joshi, Tracking of multimodal therapeutic nanocomplexes targeting breast cancer in vivo. Nano Lett. 10, 4920 (2010).
63. S. P. Foy, R. L. Manthe, S. T. Foy, S. Dimitrijevic, N. Krishnamurthy, and V. Labhasetwar, Optical imaging and magnetic field targeting of magnetic nanoparticles in tumors. ACS Nano 4, 5217 (2010).
64. F. K. H. van Landeghem, K. Maier-Hauff, A. Jordan, K. T. Hoffmann, U. Gneveckow, R. Scholz, B. Thiesen, W. Bruck, and A. von Deimling, Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials 30, 52 (2009).
65. C. Vauthier, N. Tsapis, and P. Couvreur, Nanoparticles: Heating tumors to death? Nanomedicine 6, 99 (2011).
66. S. Purushotham, P. E. J. Chang, H. Rumpel, I. H. C. Kee, R. T. H. Ng, P. K. H. Chow, C. K. Tan, and R. V. Ramanujan, Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy. Nanotechnology 20, 11 (2009).
67. Q. A. Pankhurst, J. Connolly, S. K. Jones, and J. Dobson, Applications of magnetic nanoparticles in biomedicine. J. Phys. D Appl. Phys. 36, R167 (2003).
68. J. Xie, J. Huang, X. Li, S. Sun, and X. Chen, Iron oxide nanoparticle platform for biomedical applications. Curr. Med. Chem. 16, 1278 (2009).
69. E. Q. Song, J. Hu, C. Y. Wen, Z. Q. Tian, X. Yu, Z. L. Zhang, Y. B. Shi, and D. W. Pang, Fluorescent-magnetic-biotargeting multifunctional nanobioprobes for detecting and isolating multiple types of tumor cells. ACS Nano 5, 761 (2011).
70. B. Sampedro, P. Crespo, A. Hernando, R. Litrán, J. C. Sánchez López, C. López Cartes, A. Fernández, J. Ramírez, J. González-Calbet, and M. Vallet-Regí, Ferromagnetism in fcc twinned 2.4 nm size Pd nanoparticles. Phys. Rev. Lett. 91, 237203 (2003).
71. M. A. García, M. L. Ruiz-González, G. De la Fuente, P. Crespo, J. M. González, J. M. González-Calbet, M. Vallet-Regí, and A. Hernando, Ferromagnetism in twinned Pt nanoparticles obtained by laser ablation. Chem. Mater. 19, 889 (2007).
72. A. K. Gupta and M. Gupta, Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26, 3995 (2005).
73. S. Laurent, D. Forge, M. Port, A. Roch, C. Robic, L. Vander Elst, and R. N. Muller, Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 108, 2064 (2008).
74. B. Polyak and G. Friedman, Magnetic targeting for site-specific drug delivery: Applications and clinical potential. Expert Opin. Drug Del. 6, 53 (2009).
75. M. Arruebo, R. Fernández-Pacheco, M. R. Ibarra, and J. Santamaría, Magnetic nanoparticles for drug delivery. Nano Today 2, 22 (2007).
76. M. K. Yu, Y. Y. Jeong, J. Park, S. Park, J. W. Kim, J. J. Min, K. Kim, and S. Jon, Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. Angew. Chem. Int. Ed. 47, 5362 (2008).
77. S. Mornet, S. Vasseur, F. Grasset, and E. Duguet, Magnetic nanoparticle design for medical diagnosis and therapy. J. Mater. Chem. 14, 2161 (2004).
78. B. Thierry, F. Al-Ejeh, M. P. Brown, P. Majewski, and H. J. Griesser, Immunotargeting of functional nanoparticles for MRI detection of apoptotic tumor cells. Adv. Mater. 21, 541 (2009).
79. A. J. Cole, A. E. David, J. Wang, C. J. Galban, H. L. Hill, and V. C. Yang, Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials 32, 2183 (2011).
80. F. Danhier, O. Feron, and V. Preat, To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control. Release 148, 135 (2010).
81. G. Storm, S. O. Belliot, T. Daemen, and D. D. Lasic, Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv. Drug Deliver. Rev. 17, 31 (1995).
82. A. S. Manjappa, K. R. Chaudhari, M. P. Venkataraju, P. Dantuluri, B. Nanda, C. Sidda, K. K. Sawant, and R. S. R. Murthy, Antibody derivatization and conjugation strategies: Application in preparation of stealth immunoliposome to target chemotherapeutics to tumor. J. Control. Release 150, 2 (2011).
83. A. D. Grief and G. Richardson, Mathematical modelling of magnetically targeted drug delivery. J. Magn. Magn. Mater. 293, 455 (2005).
84. O. Rotariu and N. J. C. Strachan, Modelling magnetic carrier particle targeting in the tumor microvasculature for cancer treatment. J. Magn. Magn. Mater. 293, 639 (2005).
85. R. Probst, J. Lin, A. Komaee, A. Nacev, Z. Cummins, and B. Shapiro, Planar steering of a single ferrofluid drop by optimal minimum power dynamic feedback control of four electromagnets at a distance. J. Magn. Magn. Mater. 323, 885 (2011).
86. B. Shapiro, Towards dynamic control of magnetic fields to focus magnetic carriers to targets deep inside the body. J. Magn. Magn. Mater. 321, 1594 (2009).
87. P. A. Kramer, Albumin microspheres as vehicles for achieving specificity in drug delivery. J. Pharm. Sci. 63, 1646 (1974).
88. P. K. Gupta and C. T. Hung, Comparative disposition of adriamycin delivered via magnetic albumin microspheres in presence and absence of magnetic-field in rats. Life Sci. 46, 471 (1990).
89. S. R. Deka, A. Quarta, R. Di Corato, A. Riedinger, R. Cingolani, and T. Pellegrino, Magnetic nanobeads decorated by thermoresponsive PNIPAM shell as medical platforms for the efficient delivery of doxorubicin to tumour cells. Nanoscale 3, 619 (2011).
90. J. Zhang and R. D. K. Misra, Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: Core-shell nanoparticle carrier and drug release response. Acta Biomater. 3, 838 (2007).
91. S. F. Medeiros, A. M. Santos, H. Fessi, and A. Elaissari, Stimuliresponsive magnetic particles for biomedical applications. Int. J. Pharm. 403, 139 (2011).
92. M. C. Urbina, S. Zinoveva, T. Miller, C. M. Sabliov, W. T. Monroe, and C. Kumar, Investigation of magnetic nanoparticle-polymer composites for multiple-controlled drug delivery. J. Phys. Chem. C 112, 11102 (2008).
93. R. Fuhrer, E. K. Athanassiou, N. A. Luechinger, and W. J. Stark, Crosslinking metal nanoparticles into the polymer backbone of hydrogels enables preparation of soft, magnetic field-driven actuators with muscle-like flexibility. Small 5, 383 (2009).
94. X. Q. Liu, M. D. Kaminski, H. T. Chen, M. Torno, L. Taylor, and A. J. Rosengart, Synthesis and characterization of highly-magnetic biodegradable poly(D, L-lactide-co-glycolide) nanospheres. J. Control. Release 119, 52 (2007).
95. H. X. Wu, G. Liu, S. J. Zhang, J. L. Shi, L. X. Zhang, Y. Chen, F. Chen, and H. R. Chen, Biocompatibility, MR imaging and targeted drug delivery of a rattle-type magnetic mesoporous silica nanosphere system conjugated with PEG and cancer-cell-specific ligands. J. Mater. Chem. 21, 3037 (2011).
96. T. Hoare, B. P. Timko, J. Santamaria, G. F. Goya, S. Irusta, S. Lau, C. F. Stefanescu, D. B. Lin, R. Langer, and D. S. Kohane, Magnetically triggered nanocomposite membranes: A versatile platform for triggered drug release. Nano Lett. 11, 1395 (2011).
97. Q. Yuan, R. Venkatasubramanian, S. Hein, and R. D. K. Misra, A stimulus-responsive magnetic nanoparticle drug carrier: Magnetite encapsulated by chitosan-grafted-copolymer. Acta Biomater. 4, 1024 (2008).
98. C. C. Berry and A. S. G. Curtis, Functionalisation of magnetic nanoparticles for applications in biomedicine. J. Phys. D Appl. Phys. 36, R198 (2003).
99. F. Scherer, M. Anton, U. Schillinger, J. Henke, C. Bergemann, A. Krüger, B. Gänsbacher, and C. Plank, Magnetofection: Enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. 9, 102 (2002).
100. J. Dobson, Gene therapy progress and prospects: Magnetic nanoparticles-based gene delivery. Gene Ther. 13, 283 (2006).
101. O. C. Farokhzad and R. Langer, Impact of nanotechnology on drug delivery. ACS Nano 3, 16 (2009).
102. P. Rivera-Gil and W. J. Parak, Composite nanoparticles take aim at cancer. ACS Nano 2, 2200 (2008).
103. A. D. Bangham, M. M. Standish, and J. C. Watkins, Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13, 238 (1965).
104. M. Vallet-Regí, F. Balas, and D. Arcos, Mesoporous materials for drug delivery. Angew. Chem., Int. Ed. 46, 7548 (2007).
105. M. Manzano, M. Colilla, and M. Vallet-Regí, Drug delivery for ordered mesoporous matrices. Expert Opin. Drug Deliv. 6, 1383 (2009).
106. B. G. Trewyn, I. I. Slowing, G. Supratim, H.-T. Chen, and V. S.-Y. Lin, Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release. Acc. Chem. Res. 40, 846 (2007).
107. Y. Zhao, J. Vivero-Escoto, I. I. Slowing, B. G. Trewyn, and V. S.-Y. Lin, Capped mesoporous silica nanoparticles as stimuliresponsive controlled release systems for intracellular drug/gene delivery. Expert Opin. Drug Deliv. 7, 1013 (2010).
108. T. W. Kim, P. W. Chung, I. I. Slowing, M. Tsunoda, E. S. Yeung, and V. S.-Y. Lin, Structurally ordered mesoporous carbon nanoparticles as transmembrane delivery vehicle in human cancer cells. Nano Lett. 8, 3724 (2008).
109. M. Kim, S. Kwonnan, H. Bin, and T. Hyeon, Synthesis of nanorattles composed of gold nanoparticles encapsulated in mesoporous carbon and polymer shells. Nano Lett. 2, 1383 (2002).
110. Z. Liu, X. M. Sun, N. Nakayama-Ratchford, and H. J. Dai, Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery. ACS Nano 1, 50 (2007).
111. A. A. Bhirde, V. Patel, J. Gavard, G. Zhang, A. A. Sousa, A. Masedunskas, R. D. Leapman, R. Weigert, J. S. Gutkind, and J. F. Rusling, Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano 3, 307 (2009).
112. C. T. Kresge, M. E. Leonowicz, W. J. Roth, J. C. Vartuli, and J. S. Beck, Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 359, 710 (1992).
113. B. G. Trewyn, S. Giri, I. I. Slowing, and V. S.-Y. Lin, Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems. Chem. Commun. 3236 (2007).
114. S. Inagaki, Y. Fukushima, and K. Kuroda, Synthesis of highly ordered mesoporous materials from a layered polysilicate. J. Chem. Soc., Chem. Commun. 680 (1993).
115. G. J. A. A. Soler-Illia, C. Sanchez, B. Lebeau, and J. Patarin, Chemical strategies to design textured materials: From microporous and mesoporous oxides to nanonetworks and hierarchical structures. Chem. Rev. 102, 4093 (2002).
116. F. Schüth, Endo-and exotemplating to create high-surface-area inorganic materials. Angew. Chem., Int. Ed. 42, 3604 (2003).
117. F. Hoffmann, M. Cornelius, J. Morell, and M. Froba, Silica-based mesoporous organic-inorganic hybrid materials. Angew. Chem., Int. Ed. 45, 3216 (2006).
118. D. R. Radu, C. Y. Lai, K. Jeftinija, E. W. Rowe, S. Jeftinija, and V. S.-Y. Lin, A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. J. Am. Chem. Soc. 126, 13216 (2004).
119. I. I. Slowing, B. G. Trewyn, and V. S.-Y. Lin, Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J. Am. Chem. Soc. 128, 14792 (2006).
120. M. Gruen, I. Lauer, and K. K. Unger, The synthesis of micrometerand submicrometer-size spheres of ordered mesoporous oxide MCM-41. Adv. Mater. 9, 254 (1997).
121. Q. Huo, J. Feng, F. Schüth, and G. D. Stucky, Preparation of hard mesoporous silica spheres. Chem. Mater. 9, 14 (1997).
122. L. Qi, J. Ma, H. Cheng, and Z. Zhao, Micrometer-sized mesoporous silica spheres grown under static conditions. Chem. Mater. 10, 1623 (1998).
123. W. Stöber, A. Fink, and E. Bohn, Controlled growth of monodisperse silica spheres in the micron size range. J. Colloid Interface Sci. 26, 62 (1968).
124. Y. F. Lu, H. Y. Fan, A. Stump, T. L. Ward, T. Rieker, and C. J. Brinker, Aerosol-assisted self-assembly of mesostructured spherical nanoparticles. Nature 398, 223 (1999).
125. C. J. Brinker, Y. F. Lu, A. Sellinger, and H. Y. Fan, Evaporationinduced self-assembly: Nanostructures made easy. Adv. Mater. 11, 579 (1999).
126. E. Ruiz-Hernández, A. López-Noriega, D. Arcos, I. Izquierdo-Barba, O. Terasaki, and M. Vallet-Regí, Aerosol-assisted synthesis of magnetic mesoporous silica spheres for drug targeting. Chem. Mater. 19, 3455 (2007).
127. F. Qu, G. Zhu, S. Huang, S. Li, J. Sun, D. Zhang, and S. Qui, Controlled release of Captopril by regulating the pore size and morphology of ordered mesoporous silica. Microporous Mesoporous Mater. 92, 1 (2006).
128. X. Li, L. X. Zhang, X. P. Dong, J. Liang, and J. L. Shi, Preparation of mesoporous calcium doped silica spheres with narrow size dispersion and their drug loading and degradation behavior. Microporous Mesoporous Mater. 102, 151 (2007).
129. D. Arcos, A. López-Noriega, and E. Ruíz-Hernández, Ordered mesoporous microspheres for bone grafting and drug delivery. Chem. Mater. 21, 1000 (2009).
130. Y. F. Zhu, J. L. Shi, H. R. Chen, W. H. Shen, and X. P. Dong, A facile method to synthesize novel hollow mesoporous silica spheres and advanced storage property. Microporous Mesoporous Mater. 84, 218 (2005).
131. F. Lu, S.-H. Wu, Y. Hung, and C.-Y. Mou, Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 5, 1408 (2009).
132. B. G. Trewyn, J. A. Nieweg, Y. Zhao, and V. S.-Y. Lin, Biocompatible mesoporous silica nanoparticles with different morphologies for animal cell membrane penetration. Chem. Eng. J. 137, 23 (2008).
133. S. P. Hudson, R. F. Padera, R. Langer, and D. S. Kohane, The biocompatibility of mesoporous silicates. Biomaterials 29, 4045 (2008).
134. Z. Tao, M. P. Morrow, T. Asefa, K. K. Sharma, C. Duncan, A. Anan, H. S. Penefsky, J. Goodisman, and A.-K. Souid, Mesoporous silica nanoparticles inhibit cellular respiration. Nano Lett. 8, 1517 (2008).
135. D.-M. Huang, T.-H. Chung, Y. Hung, F. Lu, S.-H. Wu, C.-Y. Mou, M. Yao, and Y.-C. Chen, Internalization of mesoporous silica nanoparticles induces transient but not sufficient osteogenic signals in human mesenchymal stem cells. Toxicol. Appl. Pharmacol. 231, 208 (2008).
136. J. Lu, M. Liong, Z. Li, J. I. Zink, and F. Tamanoi, Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 6, 1794 (2010).
137. Y. Zhao, X. Sun, G. Zang, B. G. Trewyn, I. I. Slowing, and V. S.-Y. Lin, Interaction of mesoporous silica nanoparticles with human red blood cell membranes: Size and surface effects. ACS Nano 5, 1366 (2011).
138. Z. Tao, B. Toms, J. Goodisman, and T. Asefa, Mesoporous silica microparticles enhance the cytotoxicity of anticancer platinum drugs. ACS Nano 4, 789 (2010).
139. Z. Tao, G. Wang, J. Goodisman, and T. Asefa, Accelerated oxidation of epinephrine by silica nanoparticles. Langmuir 25, 10183 (2009).
140. M. Vallet-Regí, A. Rámila, R. P. del Real, and J. Perez-Pariente, A new property of MCM-41: Drug delivery system. Chem. Mater. 13, 308 (2001).
141. K. K. Cotí, M. E. Belowich, M. Liong, M. W. Ambrogio, Y. A. Lau, H. A. Khatib, J. I. Zink, N. M. Khashab, and J. F. Stoddart, Mechanised nanoparticles for drug delivery. Nanoscale 1, 16 (2009).
142. I. I. Slowing, B. G. Trewyn, and V. S.-Y. Lin, Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. J. Am. Chem. Soc. 129, 8845 (2007).
143. H. Meng, M. Xue, T. Xia, Y.-L. Zhao, F. Tamanoi, J. F. Stoddart, J. I. Zink, and A. E. Nel, Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves. J. Am. Chem. Soc. 132, 12690 (2010).
144. Y.-L. Zhao, Z. Li, S. Kabehie, Y. Y. Botros, J. F. Stoddart, and J. I. Zink, pH-operated nanopistons on the surfaces of mesoporous silica nanoparticles. J. Am. Chem. Soc. 132, 13016 (2010).
145. C. Park, K. Oh, S.-C. Lee, and C. Kim, Controlled release of guest molecules from mesoporous silica particles based on a pH-responsive polypseudorotaxane motif. Angew. Chem. Int. Ed. 46, 1455 (2007).
146. L. Du, S. Liao, H. A. Khatib, J. F. Stoddart, and J. I. Zink, Controlled-access hollow mechanized silica nanocontainers. J. Am. Chem. Soc. 131, 15136 (2009).
147. R. Liu, P. Liao, J. Liu, and P. Feng, Responsive polymer-coated mesoporous silica as a pH-sensitive nanocarrier for controlled release. Langmuir 27, 3095 (2011).
148. R. Liu, Y. Zhang, X. Zhao, A. Agarwal, L. J. Mueller, and P. Feng, pH-responsive nanogated ensemble based on gold-capped mesoporous silica through an acid-labile acetal linker. J. Am. Chem. Soc. 132, 1500 (2010).
149. E. Aznar, C. Coll, M. D. Marcos, R. Martínez-Máñez, F. Sancenón, J. Soto, P. Amorós, J. Cano, and E. Ruiz, Borate-driven gatelike scaffolding using mesoporous materials functionalised with saccharides. Chem. Eur. J. 15, 6877 (2009).
150. Y.-Z. You, K. K. Kalebaila, S. L. Brock, and D. Oupický, Temperature-controlled uptake and release in PNIPAM-modified porous silica nanoparticles. Chem. Mater. 20, 3354 (2008).
151. Q. Fu, R. Rama, T. L. Ward, Y. Lu, and G. P. López, Thermoresponsive transport through ordered mesoporous silica/PNIPAAm copolymer membranes and microspheres. Langmuir 23, 170 (2007).
152. J. H. Park, Y.-H. Lee, and S.-G. Oh, Preparation of thermosensitive PNIPAm-grafted mesoporous silica particles. Macromol. Chem. Phys. 208, 2419 (2007).
153. Y. Zhu, S. Kaskel, T. Ikoma, and N. Hanagata, Magnetic SBA-15/poly(N isopropylacrylamide) composite: Preparation, characterization and temperature-responsive drug release property. Microporous Mesoporous Mater. 123, 107 (2009).
154. K. Nagase, J. Kobayashi, A. Kikuchi, Y. Akiyama, H. Kanazawa, and T. Okano, Interfacial property modulation of thermoresponsive polymer brush surfaces and their interaction with biomolecules. Langmuir 23, 9409 (2007).
155. A. Zintchenko, M. Ogris, and E. Wagner, Temperature dependent gene expression induced by PNIPAM-based copolymers: Potential of hyperthermia in gene transfer. Bioconjugate Chem. 17, 766 (2006).
156. M. Keerl, V. Smirnovas, R. Winter, and W. Richtering, Copolymer microgels from mono-and disubstituted acrylamides: Phase behavior and hydrogen bonds. Macromolecules 41, 6830 (2008).
157. T. Hoare, J. Santamaria, G. F. Goya, S. Irusta, D. Lin, S. Lau, R. Padera, R. Langer, and D. S. Kohane, A magnetically triggered composite membrane for on-demand drug delivery. Nano Lett. 9, 3651 (2009).
158. E. Illes and E. Tombacz, The effect of humic acid adsorption on pH-dependent surface charging and aggregation of magnetite nanoparticles. J. Colloid Interface Sci. 295, 115 (2006).
159. E. Ruiz-Hernández, A. López-Noriega, D. Arcos, I. Izquierdo-Barba, O. Terasaki, and M. Vallet-Regí, Aerosol-assisted synthesis of magnetic mesoporous silica spheres for drug targeting. Chem. Mater. 19, 3455 (2007).
160. T. W. Kim, P. W. Chung, and V. S. Y. Lin, Facile synthesis of monodisperse spherical MCM-48 mesoporous silica nanoparticles with controlled particle size. Chem. Mater. 22, 5093 (2010).
161. A. López-Noriega, E. Ruiz-Hernández, S. M. Stevens, D. Arcos, M. W. Anderson, O. Terasaki, and M. Vallet-Regí, Mesoporous microspheres with doubly ordered core-shell structure. Chem. Mater. 21, 18 (2009).
162. F. M. Martin-Saavedra, E. Ruiz-Hernández, A. Bore, D. Arcos, M. Vallet-Regí, and N. Vilaboa, Magnetic mesoporous silica spheres for hyperthermia therapy. Acta Biomater. 6, 4522 (2010).
163. E. Ruiz-Hernández, A. Baeza, and M. Vallet-Regí, Smart drug delivery through DNA/magnetic nanoparticle gates. ACS Nano 5, 1259 (2011).
164. R. Jin, G. Wu, Z. Li, C. A. Mirkin, and G. C. Schatz, What controls the melting properties of DNA-linked gold nanoparticle assemblies? J. Am. Chem. Soc. 125, 1643 (2003).
165. G. Kong, R. D. Braun, and M. W. Dewhirst, Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size. Cancer Res. 60, 4440 (2000).
166. J. Skitzki, E. A. Repasky, and S. S. Evans, Hypertermia as an immunotherapy strategy for cancer. Curr. Opin. Investig. Drugs 10, 550 (2009).
167. A. Schlossbauer, S. Warncke, P. M. E. Gramlich, J. Kecht, A. Manetto, T. Carell, and T. Bein, A programmable DNA-based molecular valve for colloidal mesoporous silica. Angew. Chem. Int. Ed. 49, 4734 (2010).
168. R. Liu, X. Zhao, T. Wu, and P. Feng, Tunable redox-responsive hybrid nanogated ensembles. J. Am. Chem. Soc. 130, 14418 (2008).
169. C.-Y. Lai, B. G. Trewyn, D. M. Jeftinija, K. Jeftinija, S. Xu, S. Jeftinija, and V. S.-Y. Lin, A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J. Am. Chem. Soc. 125, 4451 (2003).
170. S. Giri, B. G. Trewyn, M. P. Stellmaker, and V. S.-Y. Lin, Stimuliresponsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew. Chem. Int. Ed. 44, 5038 (2005).
171. F. Torney, B. G. Trewyn, V. S.-Y. Lin, and K. Wang, Mesoporous silica nanoparticles deliver DNA and chemicals into plants. Nat. Nanotechnol. 2, 295 (2007).
172. C. D. Austin, X. Wen, L. Gazzard, C. Nelson, R. H. Scheller, and S. J. Scales, Oxidizing potential of endosomes and lysosomes limits intracellular cleavage of disulfide-based antibody-drug conjugates. Proc. Natl. Acad. Sci. USA 102, 17987 (2005).
173. A. M. Shauer, A. Schlossbauer, N. Ruthardt, V. Cauda, T. Bein, and C. Bräuchle, Role of endosomal escape for disulfide-based drug delivery from colloidal mesoporous silica evaluated by live-cell imaging. Nano Lett. 10, 3684 (2010).
174. K. G. de Bruin, C. Fella, M. Ogris, E. Wagner, N. Ruthardt, and C. Bräuchle, Dynamics of photoinduced endosomal release of polyplexes. J. Control. Release 130, 175 (2008).
175. S. Febvay, D. M. Marini, A. M. Belcher, and D. E. Clapham, Targeted cytosolic delivery of cell-impermeable compounds by nanoparticle-mediated, light-triggered endosome disruption. Nano Lett. 10, 2211 (2010).
176. A. Høgset, L. Prasmickaite, P. K. Selbo, M. Hellum, B. Ø. Engesæter, A. Bonsted, and K. Berg, Photochemical internalisation in drug and gene delivery. Adv. Drug Deliver. Rev. 56, 95 (2004).
177. K. Berg, M. Folini, L. Prasmickaite, P. K. Selbo, A. Bonsted, B. Ø. Engesæter, N. Zaffaroni, A. Weyergang, A. Dietze, G. M. Maelandsmo, E. Wagner, O. J. Norum, and A. Hogset, Photochemical internalization: A new tool for drug delivery. Curr. Pharm. Biotechnol. 8, 362 (2007).
178. N. K. Mal, M. Fujiwara, and Y. Tanaka, Photocontrolled reversible release of guest molecules from coumarin modified mesoporous silica. Nature 421, 350 (2003).
179. Y. Zhu and M. Fujiwara, Installing dynamic molecular photomechanics in mesopores: A multifunctional controlled-release nanosystem. Angew. Chem. Int. Ed. 46, 2241 (2007).
180. S. Angelos, E. Choi, F. Vögtle, L. de Cola, and J. I. Zink, Photodriven expulsion of molecules from mesostructured silica nanoparticles. J. Phys. Chem. C 111, 6589 (2007).
181. D. P. Ferris, Y.-L. Zhao, N. M. Khashab, H. A. Khatib, J. F. Stoddart, and J. I. Zink, Light-operated mechanized nanoparticles. J. Am. Chem. Soc. 131, 1686 (2009).
182. C. Park, K. Lee, and C. Kim, Photoresponsive cyclodextrin-covered nanocontainers and their sol-gel transition induced by molecular recognition. Angew. Chem. Int. Ed. 48, 1275 (2009).
183. J. L. Vivero-Escoto, I. I. Slowing, C. W. Wu, and V. S.-Y. Lin, Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere. J. Am. Chem. Soc. 131, 3462 (2009).
184. N. Z. Knezevic, B. G. Trewyn, and V. S.-Y. Lin, Functionalized mesoporous silica nanoparticle-based visible light responsive controlled release delivery system. Chem. Commun. 47, 2817 (2011).
185. K. Patel, S. Angelos, W. R. Dichtel, A. Coskun, Y. W. Yang, J. I. Zink, and J. F. Stoddart, Enzyme-responsive snap-top covered silica nanocontainers. J. Am. Chem. Soc. 130, 2382 (2008).
186. C. Park, H. Kim, S. Kim, and C. Kim, Enzyme responsive nanocontainers with cyclodextrin gatekeepers and synergistic effects in release of guests. J. Am. Chem. Soc. 131, 16614 (2009).
187. A. Bernardos, L. Mondragón, E. Aznar, M. D. Marcos, R. Martínez-Máñez, F. Sancenón, J. Soto, J. M. Barat, E. Pérez-Payá, C. Guillem, and P. Amorós, Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "Saccharides". ACS Nano 4, 6353 (2010).
188. A. Schlossbauer, J. Kecht, and T. Bein, Biotin-avidin as a proteaseresponsive cap system for controlled guest release from colloidal mesoporous silica. Angew. Chem. Int. Ed. 48, 3092 (2009).
189. J. D. Byrne, T. Betancourt, and L. Brannon-Peppas, Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv. Drug Deliver. Rev. 60, 1615 (2008).
190. O. C. Farokhzad, J. Cheng, B. A. Teply, I. Sherifi, S. Jon, P. W. Kantoff, J. P. Richie, and R. Langer, Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. U.S.A. 103, 6315 (2006).
191. S. Mazzucchelli, M. Colombo, C. de Palma, A. Salvadè, P. Verderio, M. D. Coghi, E. Clementi, P. Tortora, F. Corsi, and D. Prosperi, Single-domain protein A-engineered magnetic nanoparticles: Toward a universal strategy to site-specific labeling of antibodies for targeted detection of tumor cells. ACS Nano 4, 5693 (2010).
192. E. Climent, A. Bernados, R. Martínez-Máñez, A. Maquieira, M. D. Marcos, N. Pastor-Navarro, R. Puchades, F. Sancenón, J. Soto, and P. Amorós, Controlled delivery systems using antibody-capped mesoporous nanocontainers. J. Am. Chem. Soc. 131, 14075 (2009).
193. R. Liu, Y. Zhang, and P. Feng, Multiresponsive supramolecular nanogated ensembles. J. Am. Chem. Soc. 131, 15128 (2009).
194. E. Aznar, M. D. Marcos, R. Martínez-Máñez, F. Sancenón, J. Soto, P. Amorós, and C. Guillem, pH-and photo-switched release of guest molecules from mesoporous silica supports. J. Am. Chem. Soc. 131, 6833 (2009).
195. R. Casasús, E. Climent, M. D. Marcos, R. Martínez-Máñez, F. Sancenón, J. Soto, P. Amorós, J. Cano, and E. Ruiz, Dual aperture control on pH-and anion-driven supramolecular nanoscopic hybrid gate-like ensembles. J. Am. Chem. Soc. 130, 1903 (2008).
196. S. Angelos, Y.-W. Yang, N. M. Khashab, J. F. Stoddart, and J. I. Zink, Dual-controlled nanoparticles exhibiting AND logic. J. Am. Chem. Soc. 131, 11344 (2009).
197. K. Mancuso, W. W. Hauswirth, Q. Li, T. B. Connor, J. A. Kuchenbecker, M. C. Mauck, J. Neitz, and M. Neitz, Gene therapy for red-green colour blindness in adult primates. Nature 461, 784 (2009).
198. A. L. Feldman and S. K. Libutti, Progress in antiangiogenic gene therapy of cancer. Cancer 89, 1181 (2000).
199. D. Moazed, Small RNAs in transcriptional gene silencing and genome defence. Nature 457, 413 (2009).
200. N. L. Rosi, D. A. Giljohann, C. S. Thaxton, A. K. R. Lytton-Jean, M. S. Han, and C. A. Mirkin, Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 312, 1027 (2006).
201. M. Selbach, B. Schwanhäusser, N. Thierfelder, Z. Fang, R. Khanin, and N. Rajewsky, Widespread changes in protein synthesis induced by microRNAs. Nature 455, 58 (2008).
202. J. Dennig and E. Duncan, Gene transfer into eukaryotic cells using activated polyamidoamine dendrimers. Rev. Mol. Biotech. 90, 339 (2002).
203. W. F. Anderson, Human gene therapy. Nature 392, 25 (1998).
204. D. J. Glover, H. J. Lipps, and D. A. Jans, Towards safe, nonviral therapeutic gene expression in humans. Nat. Rev. Genet. 6, 299 (2005).
205. M. A. Mintzer and E. E. Simanek, Nonviral vectors for gene delivery. Chem. Rev. 109, 259 (2009).
206. H. J. Yu and E. Wagner, Bioresponsive polymers for nonviral gene delivery. Curr. Opin. Mol. Ther. 11, 165 (2009).
207. K. A. Woodrow, Y. Cu, C. J. Booth, J. K. Saucier-Sawyer, M. J. Wood, and W. M. Saltzman, Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with smallinterfering RNA. Nat. Mater. 8, 526 (2009).
208. Y. C. Tseng, S. Mozumdar, and L. Huang, Lipid-based systemic delivery of siRNA. Adv. Drug Delivery Rev. 61, 721 (2009).
209. M. A. Mintzer and M. W. Grinstaff, Biomedical applications of dendrimers: A tutorial. Chem. Soc. Rev. 40, 173 (2011).
210. N. L. Rosi, D. A. Giljohann, C. S. Thaxton, A. K. R. Lytton-Jean, M. S. Han, and C. A. Mirkin, Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 312, 1027 (2006).
211. I. I. Slowing, J. L. Vivero-Escoto, C.-W. Wu, and V. S.-Y. Lin, Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliver. Rev. 60, 1278 (2008).
212. V. Sokolova and M. Epple, Inorganic nanoparticles as carriers of nucleic acids into cells. Angew. Chem. Int. Ed. 47, 1382 (2008).
213. M. De, P. S. Ghosh, and V. M. Rotello, Applications of nanoparticles in biology. Adv. Mater. 20, 4225 (2008).
214. D. Lechardeur, A. S. Verkman, and G. L. Lukacs, Intracellular routing of plasmid DNA during non-viral gene transfer. Adv. Drug Deliver. Rev. 57, 755 (2005).
215. R. Bausinger, K. von Gersdorff, K. Braeckmans, M. Ogris, E. Wagner, C. Bruchle, and A. Zumbusch, The transport of nanosized gene carriers unraveled by live-cell imaging. Angew. Chem. Int. Ed. 45, 1568 (2006).
216. H. P. Song, J. Y. Yang, S. L. Lo, Y. Wang, W. M. Fan, X. S. Tang, J. M. Xue, and S. Wang, Gene transfer using self-assembled ternary complexes of cationic magnetic nanoparticles, plasmid DNA and cell-penetrating Tat peptide. Biomaterials 31, 769 (2010).
217. M. R. Pickard, P. Barraud, and D. M. Chari, The transfection of multipotent neural precursor/stem cell transplant populations with magnetic nanoparticles. Biomaterials 32, 2274 (2011).
218. B. Steitz, H. Hofmann, S. W. Kamau, P. O. Hassa, M. O. Hottiger, B. von Rechenberg, M. Hofmann-Amtenbrink, and A. Petri-Fink, Characterization of PEI-coated superparamagnetic iron oxide nanoparticles for transfection: Size distribution, colloidal properties and DNA interaction. J. Magn. Magn. Mater. 311, 300 (2007).
219. M. Arsianti, M. Lim, C. P. Marquis, and R. Amal, Assembly of polyethylenimine-based magnetic iron oxide vectors: Insights into gene delivery. Langmuir 26, 7314 (2010).
220. R. Namgung, K. Singha, M. K. Yu, S. Jon, Y. S. Kim, Y. Ahn, I.-K. Park, and W. J. Kim, Hybrid superparamagnetic iron oxide nanoparticle-branched polyethylenimine magnetoplexes for gene transfection of vascular endothelial cells. Biomaterials 31, 4204 (2010).
221. H. Lee, E. Lee, D. K. Kim, N. K. Jang, Y. Y. Jeong, and S. Jon, Antibiofouling polymer-coated superparamagnetic iron oxide nanoparticles as potential magnetic resonance contrast agents for in vivo cancer imaging. J. Am. Chem. Soc. 128, 7383 (2006).
222. B. González, E. Ruiz-Hernández, M. J. Feito, C. López de Laorden, D. Arcos, C. Ramírez-Santillán, C. Matesanz, M. T. Portolés and M. Vallet-Regí, Covalently bonded dendrimer-maghemite nanosystems: Nonviral vectors for in vitro gene magnetofection. J. Mater. Chem. 21, 4598 (2011).
223. S. H. Wang, X. Shi, M. Van Antwerp, Z. Cao, S. D. Swanson, X. Bi, and J. R. Baker, Jr., Dendrimer-functionalized iron oxide nanoparticles for specific targeting and imaging of cancer cells. Adv. Funct. Mater. 17, 3043 (2007).
224. X. Shi, S. H. Wang, S. D. Swanson, S. Ge, Z. Cao, M. E. Van Antwerp, K. J. Landmark, and J. R. Baker, Jr., Dendrimerfunctionalized shell-crosslinked iron oxide nanoparticles for invivo magnetic resonance imaging of tumors. Adv. Mater. 20, 1671 (2008).
225. R. Abu-Reziq, H. Alper, D. Wang, and M. L. Post, Metal supported on dendronized magnetic nanoparticles: Highly selective hydroformylation catalysts. J. Am. Chem. Soc. 128, 5279 (2006).
226. B. Pan, D. Cui, Y. Sheng, C. Ozkan, F. Gao, R. He, Q. Li, P. Xu, and T. Huang, Dendrimer-modified magnetic nanoparticles enhance efficiency of gene delivery system. Cancer Res. 67, 8156 (2007).
227. B. González, M. Colilla, C. López de Laorden, and M. Vallet-Regí, A novel synthetic strategy for covalently bonding dendrimers to ordered mesoporous silica: Potential drug delivery applications. J. Mater. Chem. 19, 9012 (2009).
228. P. Orth, A. Weimer, G. Kaul, D. Kohn, M. Cucchiarini, and H. Madry, Analysis of novel nonviral gene transfer systems for gene delivery to cells of the musculoskeletal system. Mol. Biotechnol. 38, 137 (2008).
229. M. Vallet-Regí and J. M. González-Calbet, Calcium phosphates as substitution of bone tissues. Prog. Solid State Chem. 32, 1 (2004).
230. H.-C. Wu, T.-W. Wang, M. C. Bohn, F.-H. Lin, and M. Spector, Novel magnetic hydroxyapatite nanoparticles as non-viral vectors for the glial cell line-derived neurotrophic factor gene. Adv. Funct. Mater. 20, 67 (2010).
231. H. Zhang, M.-Y. Lee, M. G. Hogg, J. S. Dordick, and S. T. Sharfstein, Gene delivery in three-dimensional cell cultures by superparamagnetic nanoparticles. ACS Nano 4, 4733 (2010).
232. F. N. Al-Deen, J. Ho, C. Selomulya, C. Ma, and Ross Coppel, Superparamagnetic nanoparticles for effective delivery of malaria DNA vaccine. Langmuir 27, 3703 (2011).
233. J. M. Rosenholm, A. Meinander, E. Peuhu, R. Niemi, J. E. Eriksson, C. Sahlgren, and M. Lindén, Targeting of porous hybrid silica nanoparticles to cancer cells. ACS Nano 3, 197 (2009).
234. T. Xia, M. Kovochich, M. Liong, J. I. Zink, and A. E. Nel, Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways. ACS Nano 2, 85 (2008).
235. T. Xia, M. Kovochich, M. Liong, H. Meng, S. Kabehie, S. George, J. I. Zink, and A. E. Nel, Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano 3, 3273 (2009).
236. A. M. Chen, M. Zhang, D. Wei, D. Stueber, O. Taratula, T. Minko, and H. He, Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. Small 5, 2673 (2009).
237. S. R. Bhattarai, E. Muthuswamy, A. Wani, M. Brichacek, A. L. Castañeda, S. L. Brock, and D. Oupicky, Enhanced gene and siRNA delivery by polycation-modified mesoporous silica nanoparticles loaded with chloroquine. Pharm. Res. 27, 2556 (2010).